Increased Risk of Complications Found in Patients With RSVApril 20th 2023
Although the 28-day mortality for patients with respiratory failure did not differ between patients with and without respiratory syncytial virus (RSV), complications were more common in those with RSV.
Higher Rates of Respiratory Support Needed in Patients Admitted With RSVApril 10th 2023
Patients who were admitted to the hospital for respiratory syncytial virus (RSV) had a higher risk of a complex hospital course and had higher rates of respiratory support compared with patients admitted for influenza.
Study Explores Mortality Rates and Risk Factors in Patients Hospitalized for RSVApril 5th 2023
A recent study found the mortality rate for patients hospitalized for respiratory syncytial virus (RSV) to be 6.6%, with approximately 25% of hospitalized patients requiring admission to the intensive care unit.
What We’re Reading: Health Insurers to Cut PA Process; Bipartisan Bill to Stop MA Overpayments; J&J Ends RSV Vaccine WorkMarch 30th 2023
Payers are looking to roll back on paperwork requirements for prior authorization (PA); CMS and Medicare Advantage (MA) insurers battle over new regulations; Johnson & Johnson (J&J) falls behind Pfizer and GSK for vaccine approval.
High Levels of RSV Linked With Respiratory Infections Detected Right Before the PandemicMarch 29th 2023
The incidence of respiratory syncytial virus (RSV)–positive acute respiratory infection (ARI) was found to be significant in the period prior to the COVID-19 pandemic in older adults.
What We’re Reading: Child RSV Shot Disparities; Hospital Transparency Compliance; Abortion Pill BansFebruary 6th 2023
A pediatric shot for respiratory syncytial virus (RSV) may not be covered as a free routine vaccine; hospitals fail to comply with payment transparency rules; the fate of abortion pills is in the hands of conservative judges
Amount of Low-Income Young Children and Older Adult Hospitalizations Due to RSV Is Substantially UnderestimatedNovember 4th 2022
Children and families living in low-income neighborhoods have the highest rate of respiratory syncytial virus (RSV) hospitalizations, according to researchers.
RSV Linked With Hospital Mortality Rates Typically Seen With the FluJune 28th 2022
Patients with respiratory syncytial virus infection (RSV) were also more likely to have underlying chronic respiratory conditions and other comorbidities, according to a recent study looking at people hospitalized in ICUs.